RCAN1-mediated calcineurin inhibition as a target for cancer therapy

• Hauptverfasser: Mengyi Lao (Verfasst von), Xiaozhen Zhang (Verfasst von), Hanshen Yang (Verfasst von), Xueli Bai (Verfasst von), Tingbo Liang (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2022-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Cancer is the leading cause of mortality worldwide. Regulator of calcineurin 1 (RCAN1), as a patent endogenous inhibitor of calcineurin, plays crucial roles in the pathogenesis of cancers. Except for hypopharyngeal and laryngopharynx cancer, high expression of RCAN1 inhibits tumor progressi...